マーケットレポート詳細
造影剤市場：2029年に至るタイプ別、適応症別予測
Contrast Media Market by Type (Iodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, CT, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) - Global Forecast to 2029
- 出版元：MarketsandMarkets
出版元について - 発行年：2024年 2月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文279ページになります。
- 商品コード：MAM3545
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
造影剤の世界市場規模は2023年で63億ドル、2029年に97億ドル、市場の平均年成長率は7.5%にて増加すると見込まれています。
レポートは造影剤の世界市場について2029年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（タイプ別市場、形状別市場、等）を中心に構成されています。また競合状況、主要企業情報（14社）、平均価格分析、貿易分析なども加味し、造影剤市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆造影剤市場の世界市場予測2021-2029年
・市場規模(US$)
◆タイプ別、市場-2029年
・ヨウ素化造影剤
・ガドリニウム系造影剤
・マイクロバブル造影剤
・バリウム系造影剤
※(市場規模US$)
◆形状別、市場-2029年
・液体
・粉末
・その他形状
※(市場規模US$)
◆モダリティ別、市場-2029年
・X線
・コンピュータ断層撮影（CT）
・核磁気共鳴画像法（MRI）
・超音波
※(市場規模US$)
◆投与経路別、市場-2029年
・血管内経路
・経口経路
・直腸経路
・その他経路
※(市場規模US$)
◆適応症別、市場-2029年
・心血管疾患
・がん
・消化器疾患
・筋骨格系疾患
・神経系疾患
・腎疾患
※(市場規模US$)
◆用途別、市場-2029年
・放射線医学
・画像下治療
・インターベンショナル・カーディオロジー
※(市場規模US$)
◆エンドユーザー別、市場-2029年
・病院、診療所、外来手術センター
・画像診断センター
※(市場規模US$)
◆主要国地域別市場-2029年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国
・インド、オーストラリア
・その他アジア太平洋
その他地域
・中南米
・中東アフリカ
・GCC諸国
※地域別に、全セグメント別の細分化データ掲載
※国別にタイプ別、モダリティ別、経路投与別、用途別、適応症別、エンドユーザー別の細分化データ掲載詳細、目次参照
◆市場分析
・市場ダイナミクス
・バリューチェーン分析
・サプライチェーン分析
・技術分析
・ファイブフォース分析
・規制状況
・特許分析
・平均価格分析
・貿易分析
・エコシステム分析
・主要なステークホルダーと購買基準
・競合状況
・市場シェア分析
◆造影剤市場の主要企業プロフィール動向
・GE HEALTHCARE
・BRACCO IMAGING SPA
・BAYER AG
・GUERBET
・LANTHEUS MEDICAL IMAGING
・UNIJULES LIFE SCIENCES LTD
・JB CHEMICALS & PHARMACEUTICALS LIMITED
・SANOCHEMIA PHARMAZEUTIKA
・TAEJOON PHARM CO, LTD
・JODAS EXPOIM
・IMAX DIAGNOSTIC IMAGING LIMITED
・YANGTZE RIVER PHARMACEUTICAL GROUP
・LIVEALTH BIOPHARMA
・BEIJING BEILU PHARMACEUTICAL CO, LTD
その他企業
・UNISPIRE BIOPHARMA PRIVATE LIMITED
・ARCO LIFESCIENCES (I) PVT LTD
・STANEX DRUGS & CHEMICALS PVT LTD
・REGE IMAGING & CINE FILMS PRIVATE LIMITED
・K DIAM EXIM
・ONKO İLAÇ SAN VE TIC AŞ
・FRESENIUS KABI
・BIEM İLAÇ SAN VE TIC AŞ
・ADVACARE PHARMA
（全279頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED 25
・ FIGURE 1 CONTRAST MEDIA MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED 26
1.4 CURRENCY
1.5 MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 PRIMARY SOURCES
2.1.2.2 KEY DATA FROM PRIMARY SOURCES
2.1.2.3 KEY INDUSTRY INSIGHTS
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
・ FIGURE 5 REVENUE SHARE ANALYSIS
・ FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH 37
・ FIGURE 7 CONTRAST MEDIA MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.5.1 MARKET ASSUMPTIONS
2.5.2 GROWTH RATE ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
・ TABLE 1 RISK ASSESSMENT ANALYSIS
2.8 RECESSION IMPACT
3 EXECUTIVE SUMMARY
・ FIGURE 9 CONTRAST MEDIA MARKET, BY TYPE, 2023 VS. 2029 (USD BILLION)
・ FIGURE 10 CONTRAST MEDIA MARKET, BY FORM, 2023 VS. 2029 (USD BILLION)
・ FIGURE 11 CONTRAST MEDIA MARKET, BY MODALITY, 2023 VS. 2029 (USD BILLION)
・ FIGURE 12 CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2023 VS. 2029 (USD BILLION)
・ FIGURE 13 CONTRAST MEDIA MARKET, BY INDICATION, 2023 VS. 2029 (USD BILLION)
・ FIGURE 14 CONTRAST MEDIA MARKET, BY APPLICATION, 2023 VS. 2029 (USD BILLION)
・ FIGURE 15 CONTRAST MEDIA MARKET, BY END USER, 2023 VS. 2029 (USD BILLION)
・ FIGURE 16 GEOGRAPHICAL SNAPSHOT OF CONTRAST MEDIA MARKET
4 PREMIUM INSIGHTS
4.1 CONTRAST MEDIA MARKET OVERVIEW
・ FIGURE 17 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
4.2 NORTH AMERICA: CONTRAST MEDIA MARKET, BY END USER & COUNTRY (2022)
・ FIGURE 18 HOSPITALS, CLINICS, & AMBULATORY SURGERY CENTERS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
4.3 CONTRAST MEDIA MARKET: REGIONAL MIX
・ FIGURE 19 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.4 CONTRAST MEDIA MARKET: DEVELOPED VS. DEVELOPING MARKETS
・ FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
4.5 CONTRAST MEDIA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 21 CHINA AND INDIA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 22 CONTRAST MEDIA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 RISING PREVALENCE OF CHRONIC DISEASES
・ TABLE 2 CANCER INCIDENCE, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
・ TABLE 3 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2020 VS. 2030 VS. 2040
5.2.1.2 GROWING NUMBER OF APPROVALS OF CONTRAST MEDIA
5.2.1.3 RISING VOLUME OF CT AND MRI EXAMINATIONS PERFORMED
・ TABLE 4 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019–2021
・ TABLE 5 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019–2021
5.2.1.4 GROWING NUMBER OF DIAGNOSTIC CENTERS AND HOSPITALS
5.2.1.5 AVAILABILITY OF REIMBURSEMENT
5.2.1.6 INCREASING DEMAND FOR EARLY DISEASE DIAGNOSIS
5.2.1.7 INCREASING FUNDING BY PUBLIC-PRIVATE ORGANIZATIONS
・ TABLE 6 LIST OF BENEFICIARY HOSPITALS OF NHS WALES
5.2.2 RESTRAINTS
5.2.2.1 SIDE-EFFECTS AND RISKS OF ALLERGIC REACTIONS ASSOCIATED WITH CONTRAST MEDIA
・ TABLE 7 LIST OF SIDE-EFFECTS/REACTIONS TO CONTRAST MEDIA
5.2.3 OPPORTUNITIES
5.2.3.1 GENERIC CONTRAST MEDIA
5.2.3.2 INCREASING RESEARCH ON CONTRAST MEDIA
・ TABLE 8 INDICATIVE LIST OF RESEARCH STUDIES
5.2.3.3 GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
5.2.3.4 INCREASING DEMAND FOR MINIMALLY INVASIVE IMAGING PROCEDURES
5.2.4 CHALLENGES
5.2.4.1 PREFERENCE FOR ALTERNATIVE MODALITIES OF IMAGING THAT DO NOT REQUIRE CONTRAST MEDIA
5.2.4.2 RESTRICTION OF LINEAR GADOLINIUM-BASED CONTRAST MEDIA AND PRODUCT RECALLS
5.2.4.3 DEARTH OF TRAINED PROFESSIONALS
・ TABLE 9 US: METROPOLITAN AREAS WITH HIGH EMPLOYMENT LEVELS FOR RADIOLOGY TECHNOLOGISTS AND TECHNICIANS, 2022
5.2.4.4 SHORTAGE OF CONTRAST MEDIA
5.3 VALUE CHAIN ANALYSIS
・ FIGURE 23 VALUE CHAIN ANALYSIS: CONTRAST MEDIA MARKET
5.4 SUPPLY CHAIN ANALYSIS
・ FIGURE 24 SUPPLY CHAIN ANALYSIS: CONTRAST MEDIA MARKET
5.5 TECHNOLOGY ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 INTENSITY OF COMPETITIVE RIVALRY
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 THREAT OF SUBSTITUTES
5.7 REGULATORY LANDSCAPE
・ TABLE 10 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING CONTRAST MEDIA MARKET
5.7.1 EU REGULATIONS
5.7.2 FDA REGULATIONS 68
5.7.3 JPMA REGULATIONS 69
5.8 PATENT ANALYSIS
・ FIGURE 25 PATENT ANALYSIS: IODINATED CONTRAST MEDIA
・ FIGURE 26 PATENT ANALYSIS: GADOLINIUM-BASED CONTRAST MEDIA
5.9 KEY CONFERENCES & EVENTS IN 2024–2025
・ TABLE 11 LIST OF CONFERENCES & EVENTS IN CONTRAST MEDIA MARKET
5.10 PRICING ANALYSIS
・ TABLE 12 AVERAGE SELLING PRICE OF CONTRAST MEDIA
5.11 TRADE ANALYSIS
・ TABLE 13 IMPORT DATA FOR OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS AND DIAGNOSTIC REAGENTS FOR ADMINISTRATION TO PATIENTS, BY COUNTRY, 2018–2022 (USD MILLION)
・ TABLE 14 EXPORT DATA FOR OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS AND DIAGNOSTIC REAGENTS FOR ADMINISTRATION TO PATIENTS, BY COUNTRY, 2018–2022 (USD MILLION)
5.12 ECOSYSTEM ANALYSIS
・ FIGURE 27 ECOSYSTEM ANALYSIS: CONTRAST MEDIA MARKET
・ TABLE 15 ROLE IN ECOSYSTEM
・ FIGURE 28 KEY PLAYERS OPERATING IN CONTRAST MEDIA MARKET
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
・ TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
5.14.2 BUYING CRITERIA
・ FIGURE 30 KEY BUYING CRITERIA FOR TOP END USERS
・ TABLE 17 KEY BUYING CRITERIA FOR END USERS
6 CONTRAST MEDIA MARKET, BY TYPE
6.1 INTRODUCTION
・ TABLE 18 CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
6.2 IODINATED CONTRAST MEDIA
6.2.1 HIGH DEMAND FOR IODINATED CONTRAST MEDIA DUE TO HIGHER DOSAGE REQUIRED IN CT SCANS—KEY FACTOR DRIVING MARKET GROWTH
・ TABLE 19 IODINATED CONTRAST MEDIA MARKET, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 20 IODINATED CONTRAST MEDIA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.3 GADOLINIUM-BASED CONTRAST MEDIA
6.3.1 SUSPICION REGARDING SAFETY PROFILE TO CHALLENGE MARKET GROWTH
・ TABLE 21 GADOLINIUM-BASED CONTRAST MEDIA MARKET, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 22 GADOLINIUM-BASED CONTRAST MEDIA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.4 MICROBUBBLE CONTRAST MEDIA
6.4.1 EXTREMELY POPULAR AMONG PHYSICIANS WORLDWIDE
・ TABLE 23 MICROBUBBLE CONTRAST MEDIA MARKET, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 24 MICROBUBBLE CONTRAST MEDIA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
6.5 BARIUM-BASED CONTRAST MEDIA
6.5.1 ADVERSE EFFECTS ASSOCIATED WITH USE TO NEGATIVELY IMPACT MARKET
・ TABLE 25 BARIUM-BASED CONTRAST MEDIA MARKET, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 26 BARIUM-BASED CONTRAST MEDIA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
7 CONTRAST MEDIA MARKET, BY FORM
7.1 INTRODUCTION
・ TABLE 27 CONTRAST MEDIA MARKET, BY FORM, 2021–2029 (USD MILLION)
7.2 LIQUID
7.2.1 INCREASING ADOPTION OF EASY-TO-USE LIQUID FORM OF CONTRAST MEDIA ACROSS HOSPITALS AND DIAGNOSTIC CENTERS TO DRIVE MARKET
・ TABLE 28 LIQUID CONTRAST MEDIA MARKET, BY REGION, 2021–2029 (USD MILLION)
7.3 POWDER
7.3.1 EASE OF HANDLING, STORAGE, AND TRANSPORTATION TO FAVOR ADOPTION
・ TABLE 29 POWDER CONTRAST MEDIA MARKET, BY REGION, 2021–2029 (USD MILLION)
7.4 OTHER FORMS 93
・ TABLE 30 CONTRAST MEDIA MARKET FOR OTHER FORMS, BY REGION, 2021–2029 (USD MILLION)
8 CONTRAST MEDIA MARKET, BY MODALITY
8.1 INTRODUCTION
・ TABLE 31 NUMBER OF PROCEDURES PERFORMED, BY MODALITY, 2017–2020
・ TABLE 32 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2021–2029 (MILLION LITERS)
・ TABLE 33 CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
8.2 X-RAY
8.2.1 PRODUCTION OF HIGH-QUALITY IMAGES TO DRIVE MARKET
・ TABLE 34 UK: NUMBER OF X-RAY TESTS PERFORMED, 2012–2020
・ TABLE 35 CONTRAST MEDIA MARKET FOR X-RAY, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 36 CONTRAST MEDIA MARKET FOR X-RAY, BY COUNTRY, 2021–2029 (USD MILLION)
8.3 CT
8.3.1 INCREASING NUMBER OF CT EXAMINATIONS TO PROPEL MARKET
・ TABLE 37 NUMBER OF CT SCANNERS PER 1,000 INHABITANTS, BY COUNTRY, 2020 VS. 2021
・ TABLE 38 UK: NUMBER OF CT SCANS PERFORMED, 2012–2020
・ TABLE 39 CONTRAST MEDIA MARKET FOR CT, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 40 CONTRAST MEDIA MARKET FOR CT, BY COUNTRY, 2021–2029 (USD MILLION)
8.4 MRI
8.4.1 ADVANTAGES OF MRI OVER OTHER IMAGING MODALITIES TO SUPPORT MARKET GROWTH
・ TABLE 41 NUMBER OF MRI UNITS PER 1,000 INHABITANTS, BY COUNTRY, 2019 VS. 2020 VS. 2021
・ TABLE 42 UK: NUMBER OF MRI TESTS PERFORMED, 2012–2020
・ TABLE 43 CONTRAST MEDIA MARKET FOR MRI, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 44 CONTRAST MEDIA MARKET FOR MRI, BY COUNTRY, 2021–2029 (USD MILLION)
8.5 ULTRASOUND 104
8.5.1 FLEXIBLE AND LOW-COST DIAGNOSTIC IMAGING MODALITY–KEY FACTORS DRIVING MARKET GROWTH
・ TABLE 45 UK: NUMBER OF ULTRASOUND TESTS PERFORMED, 2012–2020
・ TABLE 46 CONTRAST MEDIA MARKET FOR ULTRASOUND, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 47 CONTRAST MEDIA MARKET FOR ULTRASOUND, BY COUNTRY, 2021–2029 (USD MILLION)
9 CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION
9.1 INTRODUCTION
・ TABLE 48 CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
9.2 INTRAVASCULAR ROUTE
9.2.1 WIDESPREAD USE OF INTRAVASCULAR ROUTE IN IMAGING MODALITIES TO DRIVE MARKET
9.2.1.1 INTRAVENOUS (IV) ROUTE
9.2.1.2 INTRA-ARTERIAL (IA) ROUTE
・ TABLE 49 CONTRAST MEDIA MARKET FOR INTRAVASCULAR ROUTE, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 50 CONTRAST MEDIA MARKET FOR INTRAVASCULAR ROUTE, BY COUNTRY, 2021–2029 (USD MILLION)
9.3 ORAL ROUTE 112
9.3.1 USE OF ORAL CONTRAST MEDIA CAN LEAD TO PERFORATIONS IN GIT, LEADING TO PERITONITIS
・ TABLE 51 CONTRAST MEDIA MARKET FOR ORAL ROUTE, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 52 CONTRAST MEDIA MARKET FOR ORAL ROUTE, BY COUNTRY, 2021–2029 (USD MILLION)
9.4 RECTAL ROUTE
9.4.1 MILD DISCOMFORT ASSOCIATED WITH RECTAL CONTRAST MEDIA TO LIMIT MARKET GROWTH
・ TABLE 53 CONTRAST MEDIA MARKET FOR RECTAL ROUTE, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 54 CONTRAST MEDIA MARKET FOR RECTAL ROUTE, BY COUNTRY, 2021–2029 (USD MILLION)
9.5 OTHER ROUTES
・ TABLE 55 CONTRAST MEDIA MARKET FOR OTHER ROUTES, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 56 CONTRAST MEDIA MARKET FOR OTHER ROUTES, BY COUNTRY, 2021–2029 (USD MILLION)
10 CONTRAST MEDIA MARKET, BY INDICATION
10.1 INTRODUCTION
・ TABLE 57 CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
10.2 CARDIOVASCULAR DISEASE
10.2.1 HIGH BURDEN OF CVD TO DRIVE MARKET
・ TABLE 58 CONTRAST MEDIA MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 59 CONTRAST MEDIA MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2021–2029 (USD MILLION)
10.3 CANCER
10.3.1 ASIA PACIFIC MARKET TO REGISTER RELATIVELY HIGHER GROWTH OWING TO HIGH CANCER PREVALENCE IN REGION
・ TABLE 60 CANCER INCIDENCE, BY REGION, 2020 VS. 2035 (MILLION)
・ TABLE 61 CONTRAST MEDIA MARKET FOR CANCER, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 62 CONTRAST MEDIA MARKET FOR CANCER, BY COUNTRY, 2021–2029 (USD MILLION)
10.4 GASTROINTESTINAL DISORDERS
10.4.1 RISING PREVALENCE OF GI DISORDERS TO SUPPORT MARKET GROWTH
・ TABLE 63 CONTRAST MEDIA MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 64 CONTRAST MEDIA MARKET FOR GASTROINTESTINAL DISORDERS, BY COUNTRY, 2021–2029 (USD MILLION)
10.5 MUSCULOSKELETAL DISORDERS
10.5.1 RISING INCIDENCE OF WORK-RELATED MUSCULOSKELETAL DISORDERS TO SUPPORT MARKET GROWTH
・ TABLE 65 CONTRAST MEDIA MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 66 CONTRAST MEDIA MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2021–2029 (USD MILLION)
10.6 NEUROLOGICAL DISORDERS
10.6.1 RISING PREVALENCE OF DEMENTIA TO DRIVE MARKET
・ TABLE 67 CONTRAST MEDIA MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 68 CONTRAST MEDIA MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2021–2029 (USD MILLION)
10.7 NEPHROLOGICAL DISORDERS
10.7.1 RISING PREVALENCE OF ESRD TO DRIVE DEMAND FOR DIAGNOSTIC TOOLS
・ TABLE 69 CONTRAST MEDIA MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 70 CONTRAST MEDIA MARKET FOR NEPHROLOGICAL DISORDERS, BY COUNTRY, 2021–2029 (USD MILLION)
11 CONTRAST MEDIA MARKET, BY APPLICATION
11.1 INTRODUCTION
・ TABLE 71 CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
11.2 RADIOLOGY 131
11.2.1 GROWING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE MARKET
・ TABLE 72 CONTRAST MEDIA MARKET FOR RADIOLOGY, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 73 CONTRAST MEDIA MARKET FOR RADIOLOGY, BY COUNTRY, 2021–2029 (USD MILLION)
11.3 INTERVENTIONAL RADIOLOGY
11.3.1 INCREASING POPULARITY OF MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
・ TABLE 74 CONTRAST MEDIA MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 75 CONTRAST MEDIA MARKET FOR INTERVENTIONAL RADIOLOGY, BY COUNTRY, 2021–2029 (USD MILLION)
11.4 INTERVENTIONAL CARDIOLOGY
11.4.1 RISING INCIDENCE OF CARDIAC DISEASES TO DRIVE MARKET
・ TABLE 76 CONTRAST MEDIA MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 77 CONTRAST MEDIA MARKET FOR INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2021–2029 (USD MILLION)
12 CONTRAST MEDIA MARKET, BY END USER
12.1 INTRODUCTION
・ TABLE 78 CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
12.2 HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
12.2.1 INCREASING ADOPTION OF DIAGNOSTIC IMAGING MODALITIES TO DRIVE MARKET
・ TABLE 79 CONTRAST MEDIA MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 80 CONTRAST MEDIA MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021–2029 (USD MILLION)
12.3 DIAGNOSTIC IMAGING CENTERS
12.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO PROPEL MARKET
・ TABLE 81 CONTRAST MEDIA MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 82 CONTRAST MEDIA MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2021–2029 (USD MILLION)
13 CONTRAST MEDIA MARKET, BY REGION
13.1 INTRODUCTION
・ TABLE 83 CONTRAST MEDIA MARKET, BY REGION, 2021–2029 (USD MILLION)
13.2 NORTH AMERICA
・ FIGURE 31 NORTH AMERICA: CONTRAST MEDIA MARKET SNAPSHOT
・ TABLE 84 NORTH AMERICA: CONTRAST MEDIA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 85 NORTH AMERICA: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 86 NORTH AMERICA: CONTRAST MEDIA MARKET, BY FORM, 2021–2029 (USD MILLION)
・ TABLE 87 NORTH AMERICA: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 88 NORTH AMERICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 89 NORTH AMERICA: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 90 NORTH AMERICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 91 NORTH AMERICA: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.2.1 US
13.2.1.1 RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 92 US: KEY MACROINDICATORS
・ TABLE 93 US: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 94 US: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 95 US: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 96 US: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 97 US: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 98 US: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.2.2 CANADA
13.2.2.1 INCREASING INVESTMENTS IN IMPROVING MEDICAL IMAGING TO DRIVE MARKET 153
・ TABLE 99 CANADA: KEY MACROINDICATORS 154
・ TABLE 100 CANADA: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 101 CANADA: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 102 CANADA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 103 CANADA: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 104 CANADA: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 105 CANADA: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.2.3 RECESSION IMPACT ON NORTH AMERICAN CONTRAST MEDIA MARKET
13.3 EUROPE
・ TABLE 106 EUROPE: NUMBER OF MRI UNITS PER 1,000,000 INHABITANTS, BY COUNTRY, 2021
・ TABLE 107 EUROPE: NUMBER OF MRI EXAMS PER 1,000 INHABITANTS, BY COUNTRY, 2021
・ TABLE 108 EUROPE: CONTRAST MEDIA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 109 EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 110 EUROPE: CONTRAST MEDIA MARKET, BY FORM, 2021–2029 (USD MILLION)
・ TABLE 111 EUROPE: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 112 EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 113 EUROPE: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 114 EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 115 EUROPE: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.3.1 GERMANY
13.3.1.1 PRESENCE OF WELL-DEVELOPED DIAGNOSTIC IMAGING INFRASTRUCTURE TO SUPPORT MARKET GROWTH
・ TABLE 116 GERMANY: KEY MACROINDICATORS 162
・ TABLE 117 GERMANY: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 118 GERMANY: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 119 GERMANY: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 120 GERMANY: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 121 GERMANY: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 122 GERMANY: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.3.2 FRANCE
13.3.2.1 INCREASING PREVALENCE OF CANCER TO PROPEL MARKET
・ TABLE 123 FRANCE: KEY MACROINDICATORS 165
・ TABLE 124 FRANCE: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 125 FRANCE: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 126 FRANCE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 127 FRANCE: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 128 FRANCE: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 129 FRANCE: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.3.3 UK
13.3.3.1 INCREASING INVESTMENTS IN DIAGNOSTIC IMAGING TO BOOST MARKET GROWTH 168
・ TABLE 130 UK: KEY MACROINDICATORS
・ TABLE 131 UK: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 132 UK: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 133 UK: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 134 UK: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 135 UK: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 136 UK: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.3.4 ITALY
13.3.4.1 RISING GERIATRIC POPULATION TO DRIVE DEMAND FOR DIAGNOSTIC PROCEDURES
・ TABLE 137 ITALY: KEY MACROINDICATORS 173
・ TABLE 138 ITALY: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 139 ITALY: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 140 ITALY: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 141 ITALY: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 142 ITALY: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 143 ITALY: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.3.5 SPAIN
13.3.5.1 SHORTAGE OF RADIOLOGISTS TO RESTRAIN MARKET GROWTH
・ TABLE 144 SPAIN: KEY MACROINDICATORS 176
・ TABLE 145 SPAIN: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 146 SPAIN: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 147 SPAIN: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 148 SPAIN: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 149 SPAIN: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 150 SPAIN: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.3.6 REST OF EUROPE
・ TABLE 151 REST OF EUROPE: HEALTHCARE EXPENDITURE PER CAPITA, BY COUNTRY, 2021 VS. 2022
・ TABLE 152 REST OF EUROPE: NUMBER OF MRI AND CT UNITS AND SCANS, BY COUNTRY, 2021
・ TABLE 153 REST OF EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 154 REST OF EUROPE: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 155 REST OF EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 156 REST OF EUROPE: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 157 REST OF EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 158 REST OF EUROPE: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.3.7 RECESSION IMPACT ON EUROPEAN CONTRAST MEDIA MARKET
13.4 ASIA PACIFIC
・ FIGURE 32 ASIA PACIFIC: CONTRAST MEDIA MARKET SNAPSHOT
・ TABLE 159 ASIA PACIFIC: CONTRAST MEDIA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 160 ASIA PACIFIC: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 161 ASIA PACIFIC: CONTRAST MEDIA MARKET, BY FORM, 2021–2029 (USD MILLION)
・ TABLE 162 ASIA PACIFIC: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 163 ASIA PACIFIC: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 164 ASIA PACIFIC: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 165 ASIA PACIFIC: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 166 ASIA PACIFIC: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.4.1 CHINA
13.4.1.1 HIGH INCIDENCE OF CANCER AND STROKE TO SUPPORT MARKET GROWTH
・ TABLE 167 CHINA: KEY MACROINDICATORS 188
・ TABLE 168 CHINA: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 169 CHINA: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 170 CHINA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 171 CHINA: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 172 CHINA: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 173 CHINA: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.4.2 JAPAN
13.4.2.1 STRONG HEALTHCARE SECTOR AND HIGH DISEASE INCIDENCE TO FAVOR MARKET GROWTH
・ TABLE 174 JAPAN: KEY MACROINDICATORS 191
・ TABLE 175 JAPAN: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 176 JAPAN: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 177 JAPAN: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 178 JAPAN: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 179 JAPAN: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 180 JAPAN: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.4.3 INDIA
13.4.3.1 GROWING INVESTMENTS IN RADIOLOGY TO PROPEL MARKET GROWTH
・ TABLE 181 INDIA: KEY MACROINDICATORS 194
・ TABLE 182 INDIA: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 183 INDIA: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 184 INDIA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 185 INDIA: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 186 INDIA: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 187 INDIA: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.4.4 AUSTRALIA
13.4.4.1 INCREASING RESEARCH ACTIVITIES TO DRIVE MARKET
・ TABLE 188 AUSTRALIA: KEY MACROINDICATORS
・ TABLE 189 AUSTRALIA: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 190 AUSTRALIA: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 191 AUSTRALIA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 192 AUSTRALIA: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 193 AUSTRALIA: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 194 AUSTRALIA: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.4.5 REST OF ASIA PACIFIC
・ TABLE 195 NUMBER OF MRI AND CT UNITS PER MILLION POPULATION, BY COUNTRY, 2021
・ TABLE 196 REST OF ASIA PACIFIC: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 197 REST OF ASIA PACIFIC: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 198 REST OF ASIA PACIFIC: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 199 REST OF ASIA PACIFIC: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 200 REST OF ASIA PACIFIC: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 201 REST OF ASIA PACIFIC: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.4.6 RECESSION IMPACT ON ASIA PACIFIC CONTRAST MEDIA MARKET
13.5 REST OF THE WORLD
・ TABLE 202 REST OF THE WORLD: CONTRAST MEDIA MARKET, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 203 REST OF THE WORLD: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 204 REST OF THE WORLD: CONTRAST MEDIA MARKET, BY FORM, 2021–2029 (USD MILLION)
・ TABLE 205 REST OF THE WORLD: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 206 REST OF THE WORLD: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 207 REST OF THE WORLD: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 208 REST OF THE WORLD: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 209 REST OF THE WORLD: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.5.1 LATIN AMERICA
13.5.1.1 LACK OF ADEQUATE HEALTHCARE INFRASTRUCTURE AND POOR INSURANCE COVERAGE TO LIMIT MARKET GROWTH
・ TABLE 210 LATIN AMERICA: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 211 LATIN AMERICA: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 212 LATIN AMERICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 213 LATIN AMERICA: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 214 LATIN AMERICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 215 LATIN AMERICA: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.5.2 MIDDLE EAST & AFRICA
13.5.2.1 HIGH BURDEN OF CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 216 ISRAEL: DIAGNOSTIC IMAGING DATA, 2022
・ TABLE 217 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 218 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 219 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 220 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 221 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 222 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.5.3 GCC COUNTRIES
13.5.3.1 INCREASING GOVERNMENT INVESTMENTS IN HEALTHCARE SECTOR AND GROWING PHARMACEUTICALS INDUSTRY TO DRIVE MARKET
・ TABLE 223 GCC COUNTRIES: CONTRAST MEDIA MARKET, BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 224 GCC COUNTRIES: CONTRAST MEDIA MARKET, BY MODALITY, 2021–2029 (USD MILLION)
・ TABLE 225 GCC COUNTRIES: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2021–2029 (USD MILLION)
・ TABLE 226 GCC COUNTRIES: CONTRAST MEDIA MARKET, BY INDICATION, 2021–2029 (USD MILLION)
・ TABLE 227 GCC COUNTRIES: CONTRAST MEDIA MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
・ TABLE 228 GCC COUNTRIES: CONTRAST MEDIA MARKET, BY END USER, 2021–2029 (USD MILLION)
13.5.4 RECESSION IMPACT ON REST OF THE WORLD CONTRAST MEDIA MARKET
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 STRATEGIES ADOPTED BY KEY PLAYERS
・ TABLE 229 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CONTRAST MEDIA MARKET
14.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS
・ FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN CONTRAST MEDIA MARKET
14.4 MARKET SHARE ANALYSIS
・ TABLE 230 CONTRAST MEDIA MARKET: DEGREE OF COMPETITION
・ FIGURE 34 CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER (2022)
14.5 COMPANY EVALUATION MATRIX
14.5.1 STARS
14.5.2 EMERGING LEADERS
14.5.3 PERVASIVE PLAYERS
14.5.4 PARTICIPANTS
・ FIGURE 35 CONTRAST MEDIA MARKET: COMPANY EVALUATION MATRIX, 2022
14.5.5 COMPETITIVE BENCHMARKING OF KEY PLAYERS
・ TABLE 231 FOOTPRINT ANALYSIS
・ TABLE 232 TYPE FOOTPRINT
・ TABLE 233 REGIONAL FOOTPRINT
14.6 STARTUP/SME EVALUATION MATRIX
14.6.1 PROGRESSIVE COMPANIES
14.6.2 RESPONSIVE COMPANIES
14.6.3 DYNAMIC COMPANIES
14.6.4 STARTING BLOCKS
・ FIGURE 36 CONTRAST MEDIA MARKET: STARTUP/SME EVALUATION MATRIX, 2022
14.7 COMPETITIVE BENCHMARKING
・ TABLE 234 CONTRAST MEDIA MARKET: KEY STARTUPS/SMES
14.8 COMPETITIVE SCENARIO
14.8.1 PRODUCT LAUNCHES & APPROVALS
・ TABLE 235 CONTRAST MEDIA MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–DECEMBER 2023
14.8.2 DEALS
・ TABLE 236 CONTRAST MEDIA MARKET: DEALS, JANUARY 2020–DECEMBER 2023
14.8.3 OTHER DEVELOPMENTS
・ TABLE 237 CONTRAST MEDIA MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2023
14.9 BRAND/PRODUCT COMPARISON: CONTRAST MEDIA MARKET
・ TABLE 238 BRAND/PRODUCT COMPARISON (IODINATED CONTRAST MEDIA)
・ TABLE 239 BRAND/PRODUCT COMPARISON (GADOLINIUM-BASED CONTRAST MEDIA)
15 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW)*
15.1 KEY PLAYERS 232
15.1.1 GE HEALTHCARE
・ TABLE 240 GE HEALTHCARE: BUSINESS OVERVIEW
・ FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
15.1.2 BRACCO IMAGING SPA
・ TABLE 241 BRACCO IMAGING SPA: BUSINESS OVERVIEW
15.1.3 BAYER AG
・ TABLE 242 BAYER AG: BUSINESS OVERVIEW 240
・ FIGURE 38 BAYER AG: COMPANY SNAPSHOT (2022)
15.1.4 GUERBET
・ TABLE 243 GUERBET: BUSINESS OVERVIEW 243
・ FIGURE 39 GUERBET: COMPANY SNAPSHOT (2022)
15.1.5 LANTHEUS MEDICAL IMAGING
・ TABLE 244 LANTHEUS MEDICAL IMAGING: BUSINESS OVERVIEW
・ FIGURE 40 LANTHEUS MEDICAL IMAGING: COMPANY SNAPSHOT (2022)
15.1.6 UNIJULES LIFE SCIENCES LTD. 249
・ TABLE 245 UNIJULES LIFE SCIENCES LTD.: BUSINESS OVERVIEW
15.1.7 J.B. CHEMICALS & PHARMACEUTICALS LIMITED
・ TABLE 246 J.B. CHEMICALS & PHARMACEUTICALS LIMITED: BUSINESS OVERVIEW
・ FIGURE 41 J.B. CHEMICALS & PHARMACEUTICALS LIMITED: COMPANY SNAPSHOT (2023)
15.1.8 SANOCHEMIA PHARMAZEUTIKA
・ TABLE 247 SANOCHEMIA PHARMAZEUTIKA: BUSINESS OVERVIEW
15.1.9 TAEJOON PHARM CO., LTD.
・ TABLE 248 TAEJOON PHARM CO., LTD.: BUSINESS OVERVIEW
15.1.10 JODAS EXPOIM
・ TABLE 249 JODAS EXPOIM: BUSINESS OVERVIEW
15.1.11 IMAX DIAGNOSTIC IMAGING LIMITED
・ TABLE 250 IMAX DIAGNOSTIC IMAGING LIMITED: BUSINESS OVERVIEW
15.1.12 YANGTZE RIVER PHARMACEUTICAL GROUP
・ TABLE 251 YANGTZE RIVER PHARMACEUTICAL GROUP: BUSINESS OVERVIEW
15.1.13 LIVEALTH BIOPHARMA
・ TABLE 252 LIVEALTH BIOPHARMA PVT. LTD.: BUSINESS OVERVIEW
15.1.14 BEIJING BEILU PHARMACEUTICAL CO., LTD.
・ TABLE 253 BEIJING BEILU PHARMACEUTICAL CO., LTD.: BUSINESS OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
15.2 OTHER PLAYERS
15.2.1 UNISPIRE BIOPHARMA PRIVATE LIMITED
15.2.2 ARCO LIFESCIENCES (I) PVT. LTD.
15.2.3 STANEX DRUGS & CHEMICALS PVT. LTD.
15.2.4 REGE IMAGING & CINE FILMS PRIVATE LIMITED
15.2.5 K DIAM EXIM
15.2.6 ONKO İLAÇ SAN. VE TIC. A.Ş. 266
15.2.7 FRESENIUS KABI
15.2.8 BIEM İLAÇ SAN. VE TIC. A.Ş. 268
15.2.9 ADVACARE PHARMA
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS